Nocion Therapeutics
Nocion Therapeutics is a clinical-stage biopharmaceutical company developing novel small molecule sodium channel blockers (CSCBs) to treat serious conditions involving cough, itch, and pain. Their lead program, Taplucanium, is a dry powder for inhalation targeting chronic cough. The company's mission is to alleviate suffering from conditions arising from activated sensory neurons.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $62M
Date: 04-Mar-2024
Investors: Arkin Bio Capital, Monograph Capital, Canaan Partners, F-Prime Capital, Mass General Brigham Ventures, Mission BioCapital, Osage University Partners
Markets: Biotechnology, Health Care, Medical, Biopharmaceutical, Healthtech
HQ: Watertown, Massachusetts, United States
Founded: 2017
Website: https://www.nociontx.com/
LinkedIn: https://www.linkedin.com/company/nocion-therapeutics-inc
Crunchbase: https://www.crunchbase.com/organization/nocion-therapeutics
Leave a Comment
Comments
No comments yet.